Thai-made AstraZeneca vaccines causing delays across Southeast Asia
Questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner.
Thai court orders removal of clips claiming king’s company ‘favoured’ in Covid-19 vaccine manufacture
Siam Bioscience is owned by King Maha Vajiralongkorn, and will supply the majority of doses despite an alleged lack of vaccine experience.
